Kenson Ventures
Kenson Ventures, LLC is a venture capital firm founded in 1999 and based in Palo Alto, California. It specializes in investments across various stages, including seed, startup, early-stage, mid-stage, and late-stage funding, primarily targeting emerging-growth companies in the biotechnology and life sciences sectors. The firm typically invests between $0.5 million and $3 million in private companies located in the United States, with the possibility of larger investments through co-investments with other institutions. Kenson Ventures often takes a board or advisory board seat in its portfolio companies, providing not only financial support but also strategic guidance to help companies navigate the challenges of growth. The firm has a strong focus on fostering innovation within the biotechnology field, having financed numerous companies developing novel drugs and research tools. Kenson Ventures is committed to leveraging its industry knowledge and experience to drive the success of its investments.
Turning Point Therapeutics, Inc. is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. We are focusing on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity.
Advanced Cell Diagnostics, Inc. specializes in developing and commercializing cell and tissue-based diagnostic tests aimed at advancing personalized medicine. The company employs its proprietary RNAscope technology, which enables the detection and quantification of RNA biomarkers at single-molecule sensitivity through multiplex fluorescent and chromogenic in situ hybridization. Its product offerings include manual assays, reagent kits, and catalog probes, as well as software for quantitative analysis of RNA samples and instruments for manual assay workflows. Advanced Cell Diagnostics also provides pharmaceutical assay services to facilitate understanding of disease mechanisms in preclinical research, target validation, and clinical trials. Additionally, the company has a companion diagnostic assay development program to optimize the assay development process. Its products are distributed through various channels, including international markets, and are also available for online purchase. Founded in 2007 and located in Hayward, California, the company operates as a subsidiary of Bio-Techne Corp.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.